This piece was updated in September 2018 after the launch of SPARK and in December 2017 to add contact information.
A. The Shared Platform for Antibiotic Research and Knowledge is a groundbreaking and dynamic information-sharing platform. It brings together curated antibiotic discovery data and cutting-edge analytics to help scientists tackle the scientific barriers blocking antibiotics discovery. While the global threat of antibiotic resistance continues to rise, nearly every antibiotic in use today is based on a discovery from more than 30 years ago. SPARK will focus on the unique challenges of finding and designing antibiotics that can defeat drug-resistant Gram-negative bacteria, which are among the hardest-to-treat superbugs.
A. The pipeline of products in development to treat or prevent bacterial infections is stagnant and cannot meet today’s urgent and growing patient needs. Leading experts have repeatedly identified information sharing as essential to spurring innovation; previously, however, there was no publicly available mechanism for sharing data and expertise across the antibiotic discovery research community. As a result, researchers have had difficulty benefiting from the insights of others.
Similar data-sharing tools have helped catalyze drug discovery in other research areas, such as cancer, neglected tropical diseases, and tuberculosis. Pew’s goal is for SPARK to do the same for antibiotic-resistant bacteria, by provide an impetus and a nexus for scientific inquiry in a field desperately in need of a jump-start. .
A. The information in SPARK is collated and curated by a team of antibiotic discovery experts and includes chemical and biological data relevant to understanding how molecules can get into Gram-negative bacteria and stay there, a critical factor in designing drugs that can defeat these increasingly hard-to-treat pathogens. Currently, the data is pulled from publicly available sources, such as published research articles. However, the platform has the capacity to host and integrate previously unpublished data, as well as prospective research findings from studies still in progress at academic centers and drug companies. For additional detail, see “The Data Driving SPARK.”
A. Through SPARK’s user-friendly, cloud-based interface, experts from across disciplines (e.g., biologists, chemists, computational scientists) and around the world can work together to uncover new observations, generate and share new hypotheses on how molecules enter and stay inside Gram-negative bacteria, and identify the tools and additional information needed to advance discovery.
SPARK uses technology developed by Collaborative Drug Discovery Inc. (CDD), a software company specializing in cloud-based drug discovery informatics, and is accessed via the CDD website. To optimize the platform, Pew worked with a team of antibiotic discovery experts and engaged researchers in the field to beta test the platform before launch. CDD also provides training and technical assistance to help users and data donors..
A. SPARK is publicly available for use by researchers around the world across disciplines and sectors—academia, industry, government, and nonprofits—who are focused on antibiotic innovation.
There is no cost to use SPARK. To request a log-in, please email spark-access@pewtrusts.
SPARK creates opportunities to cultivate the next generation of antibiotic discovery researchers and can serve as a valuable resource in overcoming the challenges of “brain drain” and traditionally siloed information sources. This is particularly important given that many antibiotic research programs have been abandoned or downsized in recent years, and findings from previous discovery efforts are often scattered across the academic literature or unpublished.
A. To access SPARK, go to the CDD website and enter your log-in information. This will take you directly to the SPARK interface. For an introduction to the platform’s functionality, including information on how to search available data, visit CDD’s “Quick Guide.”
A. Users can search SPARK in various ways, including by compound substructure, keywords, data source, or chemical properties such as molecular weight or pKa, a measure of acidity. The data is organized into two categories, called projects, depending on the type of data, and users can conduct searches within one or both of these data categories:
Data collections are being actively populated, so users should check back periodically to see what has been added.
Users can also draw from a Public Data project available on the CDD website, which includes information from other publicly accessible data sets.
For more information on SPARK data and how it can be used, see the following resources:
If you are interested in learning how to access and use SPARK, please email firstname.lastname@example.org